Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Breakthrough Microfluidic Test Delivers Lab-Accurate HbA1c Results in Minutes

By LabMedica International staff writers
Posted on 02 Sep 2025

For people living with diabetes, A1C testing is a key part of managing health, as it shows average blood sugar levels over the past two to three months. More...

Despite its importance, many people do not test their A1C as often as recommended, often due to inconvenience, cost, or lack of access. Now, a new portable device designed to deliver lab-quality A1C results in minutes aims to improve accessibility and frequency of monitoring.

Orange Biomed (Seattle, WA, USA) has developed the OBM rapid A1c meter, a compact handheld device for diabetes testing. The system removes protein-based reagents to improve accuracy, and its patented Micro Electro-Mechanical System mimics human microvessels within a small cartridge. The meter requires only a minimal blood sample and guides users through a simple three-step process to produce immediate results in just five minutes anywhere.

The device is intended to encourage recommended monitoring frequency, leading to better diabetes management. It also has the potential to deliver more personalized care by enabling timely, preventive interventions. With its portable format, the technology could bridge gaps in diabetes monitoring across underserved communities and reduce the risks of diabetes-related complications.

“Using advanced microfluidic technology, our platform analyzes thousands of individual red blood cells from a single drop of blood within just five minutes; significantly reducing the sample size required and enabling faster, easier testing,” said Yeaseul Park, CEO and Co-Founder of Orange Biomed. “This isn’t simply a faster version of traditional testing; it’s a fundamentally new approach. We enable more precise HbA1c measurements, which are critical for diabetes care. Many remain under-monitored due to barriers to lab testing. Our solution brings high-quality monitoring into homes, clinics, and rural settings.”

“The potential of microfluidics extends far beyond diabetes. This technology enables personalized medicine, where treatment is based on each person’s unique biological profile,” added Unghyeon Ko, Co-Founder and President of Orange Biomed, who is spearheading R&D efforts. “As microfluidic systems evolve, we envision a future where more innovators apply this technology to medical devices to form multiplexed diagnostics that integrate genomics, proteomics, and metabolomics into a single, compact platform. Imagine a future where a device on your bathroom shelf can track immune status, detect early signs of cancer, or assess medication response, all from a few drops of blood. That future is closer than we think, and microfluidics is the gateway.”

Related Links:
Orange Biomed


Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more

Industry

view channel
Image: The partnership between OGT and QIAGEN unlocks a complete sample to report workflow for SureSeq NGS panels (Photo courtesy of OGT)

Qiagen and Oxford Gene Technology Partner on Sequencing Panel Interpretation

In clinical research, next-generation sequencing (NGS) panels provide essential insights for genetic analysis, but many laboratories face challenges in transforming raw sequencing data into clinically... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.